Preventive and therapeutic effect of Ganoderma lucidum on kidney injuries and diseases
- PMID: 32089235
- DOI: 10.1016/bs.apha.2019.10.003
Preventive and therapeutic effect of Ganoderma lucidum on kidney injuries and diseases
Abstract
Ganoderma lucidum (G. lucidum, Lingzhi) is a well-known Chinese traditional medicine to improve health and to treat numerous diseases for over 2000 years in Asian countries. G. lucidum has the abundant chemical components such as triterpenes and polysaccharides, which have various biological activities including anti-oxidation, anti-inflammation, anti-liver disorders, anti-tumor growth and metastasis, etc. Recently, many lines of studies have elucidated the therapeutic effects of G. lucidum and its extractions on various acute kidney injury (AKI) and chronic kidney disease (CKD) pathogenesis, including autosomal dominant polycystic kidney disease, diabetic nephropathy, renal proximal tubular cell oxidative damage and fibrotic process, renal ischemia reperfusion injury, cisplatin-induced renal injury, adriamycin-induced nephropathy, chronic proteinuric renal diseases, etc. Clinical researches also showed potent anti-renal disease bioactivities of G. lucidum. In this chapter, we review experimental and clinical researches and provide comprehensive insights into the renoprotective effects of G. lucidum. In recent years, renal diseases have gradually aroused attention on account of their booming prevalence worldwide and lack of effective therapies. Although the complicated pathogenesis of kidney diseases, such as acute kidney injury (AKI) and chronic kidney diseases (CKD) have been intensively studied. The morbidity and mortality of AKI and CKD still rise continuously. Thanks to the conventional experience and the multi-target characteristics, natural products have been increasingly recognized as an alternative source for treating renal diseases.
Keywords: Ganoderma; Kidney disease; Kidney injury; Polysaccharides; Triterpenes.
© 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest The authors have no conflicts of interest to declare.
Similar articles
-
Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Renal Diseases and Clinical Applications.Adv Exp Med Biol. 2019;1182:243-262. doi: 10.1007/978-981-32-9421-9_10. Adv Exp Med Biol. 2019. PMID: 31777022 Review.
-
Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Skin Diseases and Care.Adv Exp Med Biol. 2019;1182:311-321. doi: 10.1007/978-981-32-9421-9_14. Adv Exp Med Biol. 2019. PMID: 31777026 Review.
-
Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Liver Injury.Adv Exp Med Biol. 2019;1182:217-242. doi: 10.1007/978-981-32-9421-9_9. Adv Exp Med Biol. 2019. PMID: 31777021 Review.
-
Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Brain Injury.Adv Exp Med Biol. 2019;1182:159-180. doi: 10.1007/978-981-32-9421-9_6. Adv Exp Med Biol. 2019. PMID: 31777018 Review.
-
Inhibition of intrarenal PRR-RAS pathway by Ganoderma lucidum polysaccharide peptides in proteinuric nephropathy.Int J Biol Macromol. 2023 Dec 31;253(Pt 7):127336. doi: 10.1016/j.ijbiomac.2023.127336. Epub 2023 Oct 16. Int J Biol Macromol. 2023. PMID: 37852403
Cited by
-
Research and application of herbal medicine in the treatment of chronic kidney disease since the 21st century: A visualized bibliometric analysis.Front Pharmacol. 2022 Sep 30;13:971113. doi: 10.3389/fphar.2022.971113. eCollection 2022. Front Pharmacol. 2022. PMID: 36249821 Free PMC article.
-
Intervention Value of Path-Type Health Education on Cognition and Renal Function of Patients with Diabetic Nephropathy.Comput Math Methods Med. 2021 Dec 22;2021:3665460. doi: 10.1155/2021/3665460. eCollection 2021. Comput Math Methods Med. 2021. Retraction in: Comput Math Methods Med. 2022 Dec 28;2022:9864762. doi: 10.1155/2022/9864762. PMID: 34976106 Free PMC article. Retracted. Clinical Trial.
-
Applications of Herbal Medicine to Treat Autosomal Dominant Polycystic Kidney Disease.Front Pharmacol. 2021 Apr 27;12:629848. doi: 10.3389/fphar.2021.629848. eCollection 2021. Front Pharmacol. 2021. PMID: 33986666 Free PMC article. Review.
-
Therapeutic potential of Ganoderma lucidum polysaccharide peptide in Doxorubicin-induced nephropathy: modulation of renin-angiotensin system and proteinuria.Front Pharmacol. 2023 Sep 29;14:1287908. doi: 10.3389/fphar.2023.1287908. eCollection 2023. Front Pharmacol. 2023. PMID: 37841924 Free PMC article.
-
Cisplatin-Induced Kidney Toxicity: Potential Roles of Major NAD+-Dependent Enzymes and Plant-Derived Natural Products.Biomolecules. 2022 Aug 5;12(8):1078. doi: 10.3390/biom12081078. Biomolecules. 2022. PMID: 36008971 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical